QIAGEN N : Form 6-K
QIAGEN N.V. By: /s/ Roland... -Today at 06:08 am- MarketScreener
Source: marketscreener.com
📰 Daniela Eltrop News
Daniela Eltrop News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniela Eltrop. Real-time updates on events, politics, business and more.
QIAGEN expands range of digital PCR kits and services for the biopharma industry
Venlo, the Netherlands, July 18, 2023 -- QIAGEN announced today the expansion of its digital PCR offering for the development of cell and gene therapies in the biopharma industry. The company...
Source: marketscreener.com
FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS) - Qiagen (NYSE:QGEN)
Venlo, the Netherlands, and San Diego, California, June 20, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)) announced today that the U.S. Federal Bureau of Investigation (FBI) has approved
Source: benzinga.com
FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)
NDIS approval provides access to federal government funding for accredited public crime laboratories in the U.S. to implement next-generation sequencing for routine casework // NGS-based ForenSeq... | June 20, 2023
Source: marketscreener.com
QIAGEN's QuantiFERON-TB Gold Plus shows unique clinical value with CD8 technology in new meta-analysis of tuberculosis screening
Venlo, the Netherlands, June 15, 2023 -- QIAGEN welcomes the publication of a new, systematic review highlighting the unique value of its proprietary tuberculosis testing technology. The study... | June 15, 2023
Source: marketscreener.com
Danish National Genome Center selects QIAGEN for variant interpretation in oncology genome sequencing - Qiagen (NYSE:QGEN)
Venlo, the Netherlands, and Redwood City, California, June 13, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced that its variant interpretation and reporting software, QIAGEN
Source: benzinga.com
QIAGEN launches QIAstat-Dx in Japan with respiratory panel for syndromic testing
Venlo, the Netherlands, April 24, 2023 -- QIAGEN announced today that its QIAstat-Dx syndromic testing solution is expected to be available soon for use in Japan with a SARS-CoV-2 Respiratory... | April 24, 2023
Source: marketscreener.com
QIAGEN N.V.: QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December
Source: finanznachrichten.de
QIAGEN N.V.: QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing
First partnership in the new QIAseq Platform Partnership to increase compatibility of QIAGEN NGS kits with third-party digital data-sharing and analytics companies Bringing together QIAGEN's
Source: finanznachrichten.de
QIAGEN's tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework
Certification of QuantiFERON-TB Gold Plus under more stringent EU regulation, classified under Class CCertification marks milestone in QIAGEN’s transition to full compliance with new EU regulations for IVD performance and safetyQIAGEN will ensure continuous supply of QuantiFERON-TB Gold PlusVENLO, The Netherlands--(...
Source: pharmiweb.com